[Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice].
D000818:Animals; D003523:Cycloserine / Q000008:administration & dosage; D004352:Drug Resistance, Microbial; D010450:Endopeptidases / Q000008:administration & dosage; D004977:Ethambutol / Q000008:administration & dosage; D005000:Ethionamide / Q000008:administration & dosage*; D007538:Isoniazid / Q000494:pharmacology; D007612:Kanamycin / Q000008:administration & dosage*; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology; D013421:Sulfamethoxypyridazine / Q000008:administration & dosage; D014376:Tuberculosis / Q000188:drug therapy*
D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D010450:Endopeptidases; D005000:Ethionamide; D013421:Sulfamethoxypyridazine; D007538:Isoniazid; D013307:Streptomycin
Der Einfluss von dem Zusatz des Dritten Mittel auf der Kombinationstherapie von Ethionamid und Kanamycin für die Mäusetuberkulose.